Alnylam Pharmaceuticals
ALNY
#625
Rank
ยฃ25.00 B
Marketcap
ยฃ193.89
Share price
1.06%
Change (1 day)
31.93%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company